Philadelphia Chromosome Positive Recruiting Phase 2 Trials for Dasatinib (DB01254)

Also known as: Philadelphia chromosome positive

IndicationStatusPhase
DBCOND0046287 (Philadelphia Chromosome Positive)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs